Hypolipoproteinemia: Difference between revisions

Jump to navigation Jump to search
 
(41 intermediate revisions by 4 users not shown)
Line 2: Line 2:
{{Hypolipoproteinemia}}
{{Hypolipoproteinemia}}
{{CMG}}; {{AE}} {{MM}}; {{AKI}}; {{TarekNafee}}
{{CMG}}; {{AE}} {{MM}}; {{AKI}}; {{TarekNafee}}
{{SK}} Hypolipidemia, low lipoprotein
==Overview==
Hypolipoproteinemia (also known as ''hypolipidemia or low lipoproteins'') is defined as presence of low levels of one or more type of [[lipoproteins]]. Hypolipoproteinemia may present as primary genetic disorders or as a secondary complication of underlying medical conditions. After ruling out common secondary causes of hypolipoproteinemia, the clinician must begin the work-up for primary causes.
Patients with hypoproteinemia may present with low [[LDL Cholesterol|LDL]], or low [[HDL]]. Patients with low LDL commonly present with [[diarrhea]], [[vomiting]], or [[failure to thrive]] (in infanthood). Patients with primary low HDL are usually asymptomatic however, patients diagnosed with low HDL due to [[Tangier's disease]], [[ApoA1|ApoA1 deficiency]], or [[LCAT deficiency]] have specific clinical findings such as [[Cornea|corneal]] opacities, [[xanthomas]], and renal failure. Work up for primary hypolipoproteinemias begins with careful examination of the [[lipid panel]] and may involve screening of family members. Confirmatory [[gene sequencing]] is the gold standard diagnostic test for all hypolipoproteinemias.
==Causes==
The following are the list of conditions which can cause low LDL C and low HDL C levels:


{{SK}} Hypolipidemia, low lipoprotein
Primary lipoprotein abnormalities
* [[Hypoalphalipoproteinemia]] (Apolipoprotein A-1 deficiency). Low HDL
* [[Hypobetalipoproteinemia]] and [[Abetalipoproteinemia]]. Low LDL and VLDL, but not low HDL
* [[Chylomicron retention disease]]
* Cholesteryl ester transfer protein (CETP) elevation
* Familial combined hypolipidemia (does not increase risk of atherosclerosis)
* [[LCAT]] deficiency
* Proprotein convertase subtilisin/kexin type 9 (PCSK9) loss of function or deficiency
* Adenosine triphosphate (ATP)-binding cassette transporter (ABCA1) gene mutations
** Familial HDL deficiency. ''This is the most common cause of low HDL and coronary artery disease.''
** [[Tangier disease]]


==Overview==
Secondary causes
Hypolipoproteinemia is defined as low levels of one or more type of [[lipoproteins]]. [[Hypolipidemia]], a commonly used term in the clinical practice, describes low level of [[lipids]], whether [[cholesterol]] or [[triglycerides]]. They are referred to as [[hypocholesterolemia]] and [[hypotriglyceridemia]] respectively. Despite being commonly used to describe abnormalities in lipid [[metabolism]], the term hypolipidemia is not very specific. For instance, people who have [[metabolic syndrome]] have high [[LDL]] and low [[HDL]] and yet they are described to have [[hyperlipidemia]] when their HDL level is decreased. Moreover, some people who have low levels of a specific lipoprotein may have a normal measured total cholesterol and triglyceride levels.
*[[Anemia]]
*[[Chronic inflammation]]
*[[Chronic liver disease]]
*Critical illness
*[[Hyperthyroidism]]
*[[Infection]]
*[[Malabsorption]]
*[[Malignancy]]


==Synopsis==
==Classification==
*It is defined as patients having LDL C less than the 5th percentile when compared to normal population.
Based on the etiology hypolipoproteinemias are classified into primary and secondary hypolipoproteinemias. The following algorithm is a list of various etiologies under primary and secondary hypolipoproteinemias:
*We have to rule out secondary causes first and then consider screening for rare genetic diseases.
{{familytree/start |summary=Hypolipoproteinemia}}
{{familytree | | | | | | | A01 | | | | | | | | A01= '''Hypolipoproteinemia'''}}
{{familytree | |,|-|-|-|-|-|^|-|-|-|-|-|-|-|-|-|.| | | }}
{{familytree | B01 | | | | | | | | | | | | | | B02 | B01= '''Primary'''<br>(Genetic)| B02= '''Secondary'''}}
{{familytree | |!| | | | | | | | | | | | | | | |!| }}
{{familytree | C01 | | | | | | | | | | | | | | C02 | C01=[[Abetalipoproteinemia]]<br> Apolipoprotein 1 deficiency <br> [[Chylomicron retention disease]] <br> Familial combined hypolipidemia <br> [[Hypobetalipoproteinemia]]<br> [[LCAT]] deficiency<br>Primary alphalipoproteinemia <br> PCSK9 deficiency <br> [[Tangier disease]]| C02= [[Anemia]] <br> Critical illness<br> [[Chronic inflammation]] <br> [[Chronic liver disease]] <br> [[Hyperthyroidism]] <br>[[Infection]] <br> [[Malabsorption]] <br>[[Malignancy]]}}
{{familytree/end}}
==Differential Diagnosis==
<small>The table below provides a brief synopsis of the lipid profile findings in several of the most common primary hypolipidemic disorders affecting the LDL C levels:
{| class="wikitable"
{| class="wikitable"
!
!
Line 81: Line 113:
|}
|}


==Classification==
The table below is a differential diagnosis for low HDL C disorders:
Shown below is an algorithm depicting the classification of hypolipoproteinemia into primary and secondary.
 
{{familytree/start |summary=Hypolipoproteinemia}}
{{familytree | | | | | | | A01 | | | | | | | | A01= '''Hypolipoproteinemia'''}}
{{familytree | |,|-|-|-|-|-|^|-|-|-|-|-|-|-|-|-|.| | | }}
{{familytree | B01 | | | | | | | | | | | | | | B02 | B01= '''Primary'''<br>(Genetic)| B02= '''Secondary'''}}
{{familytree | |!| | | | | | | | | | | | | | | |!| }}
{{familytree | C01 | | | | | | | | | | | | | | C02 | C01=[[Abetalipoproteinemia]]<br> Apolipoprotein 1 deficiency <br> [[Chylomicron retention disease]] <br> Familial combined hypolipidemia <br> [[Hypobetalipoproteinemia]]<br> [[LCAT]] deficiency<br> Primary alphalipoproteinemia <br> [[PCSK9 deficiency]] <br> [[Tangier disease]]| C02= [[Anemia]] <br> [[Criticial illness]]<br> [[Chronic inflammation]] <br> [[Chronic liver disease]] <br> [[Hyperthyroidism]] <br>[[Infection]] <br> [[Malabsorption]] <br>[[Malignancy]]}}
{{familytree/end}}
 
==Diagnostic Approach to Hypolipoproteinemias==
 
===Low LDL Diagnostic Algorithm===
The following Algorithm may be used to diagnose patients with low LDL hypolipoproteinemias:
 
{{Family tree/start}}
{{Family tree | | | | | | A01 | | | |A01= Low LDL C <5th percentile}}
{{Family tree | | | | | | |!| | | | | }}
{{Family tree | | | | | | |!| | | | | }}
{{Family tree | | | | | | C01 | | | |C01= Rule out secondary causes of low LDL}}
{{Family tree | | | | | | |!| | | | | }}
{{Family tree | | | | | | |!| | | | | }}
{{Family tree | | | | | | E01 | | | |E01= Lipid panel}}
{{Family tree | | | | | | |!| | | | | }}
{{Family tree | | |,|-|-|-|^|-|-|.|}}
{{Family tree | |F01| | | | |F02| |F01= Normal Triglycerides| F02=Low Triglycerides}}
{{Family tree | | |!| | | | | | |!| | | | | | }}
{{Family tree | |G01| | | | |G02| | | |G01=Chlyomicron retention disease<br><SMALL>(Confirm with gene sequencing)</SMALL>|G02=Screen the lipid panel of the patient's parents}}
{{Family tree | | | | | | | | | |!| | | | }}
{{Family tree | | | | | | | |,|-|^|-|-|.| }}
{{Family tree | | | | | | | H01| | |H02|H01=Normal Parental Lipid Panel|H02=If Parental Lipid Panel <50% of Normal on:<br>*LDL<br>*Total Cholesterol<br>*Triglycerides}}
{{Family tree | | | | | | | |!| | | | |!| }}
{{Family tree | | | | | | |I01| | |I02|I01=Hypobetalipoproteinemia<br><SMALL>(Confirm with gene sequencing)</SMALL>|I02=Abetalipoproteinemia<br><SMALL>(Confirm with gene sequencing)</SMALL>}}
{{Family tree/end}}
 
 
===Low HDL Diagnostic Features===
{| class="wikitable"
{| class="wikitable"
!
!
Line 129: Line 124:
!Heterozygous Tangier
!Heterozygous Tangier
Disease
Disease
!Apo A1 Deficiency
|-
|-
|Gene Defect
|Gene Defect
Line 135: Line 131:
|ABCA1
|ABCA1
|ABCA1
|ABCA1
|Apo A1
|-
|-
|Inheritance
|Inheritance
Line 141: Line 138:
|Autosomal Recessive
|Autosomal Recessive
|Autosomal Recessive
|Autosomal Recessive
|Autosomal Dominant
|-
|-
|Pathogenesis
|Pathogenesis
|Loss of alpha and beta LCAT function
|
Failure of cholesterol ester formation.
*Loss of alpha and beta LCAT function
*Failure of cholesterol ester formation.
|Loss of alpha function only
|Loss of alpha function only
|Pre beta-1 HDL fails to picks up free cholesterol from cells due to mutation in ABCA1 transporter.
|
Pre beta-1 HDL fails to picks up free cholesterol from cells due to mutation in ABCA1 transporter.
|Similar to homozygous
|Similar to homozygous
|Defective synthesis of Apo A1 resulting in failure of maturation of HDL and defective reverse cholesterol transport.
|-
|-
|Clinical Features
|Clinical Features
Line 157: Line 158:
*Corneal opacities only
*Corneal opacities only
*Normal renal function
*Normal renal function
|Large yellow-orange tonsils
|
*Large yellow-orange tonsils


Dense central corneal opacity
*Dense central corneal opacity


relapsing and remitting course of
*Relapsing and remitting course of neuropathy
 
neuropathy
|Asymptomatic
|Asymptomatic
|
*Corneal Opacities
*Tuboeruptive, Planar and palmar Xanthomas
*Premature Heart Disease
|-
|-
|Lipid Panel
|Lipid Panel
|Elevated Free cholesterol
|
*Elevated Free cholesterol


HDL-C < 10 mg/dL
*HDL-C < 10 mg/dL


Low Apo A1 and Apo A2
*Low Apo A1 and Apo AII


Elevated Apo E and Triglycerides
*Elevated Apo E and Triglycerides


Low LDL C
*Low LDL C
|Elevated free cholesterol
|
*Elevated free cholesterol


HDL C < 27 mg/dL
*HDL C < 27 mg/dL


Apo A1<30mg/dl and low Apo A2
*Apo A1<30mg/dl and low Apo A2


Elevated Apo E and Triglycerides
*Elevated Apo E and Triglycerides


Normal LDL and VLDL
*Normal LDL and VLDL
|HDL < 5% of normal
|
*HDL < 5% of normal


Apo A1 < 1% of normal
*Apo A1 < 1% of normal


LDL < 40% of normal
*LDL < 40% of normal
|HDL C, Apo A1
|
and  LDL 50% less than
*HDL C, Apo A1 and  LDL 50% less than normal.
 
|
normal.
*Undetectable Apo A1
*HDL C less than 10mg/dl
*Normal or low Apo AII
*LDL C normal
*Triglyceride normal or elevated 
|-
|-
|2D Gel Electrophoresis
|2D Gel Electrophoresis
|Pre β-1 and α-4 HDL, LDL with  β mobility due to
|Pre β-1 and α-4 HDL, LDL with  β mobility due to Lipoprotien-X
|Pre β-1and α-4 HDL with normal pre-β LDL.
|Only preβ-1 HDL present
|
*Lack of large α-1 and α-2 HDL particles
*Normal preβ-1 HDL
|Lack of Apo A1 containing HDL particles.
|}
</small>
<small>
'''Approch algorithm to a patient with low HDL C:'''<ref name="pmid23043194">{{cite journal| author=Rader DJ, deGoma EM| title=Approach to the patient with extremely low HDL-cholesterol. | journal=J Clin Endocrinol Metab | year= 2012 | volume= 97 | issue= 10 | pages= 3399-407 | pmid=23043194 | doi=10.1210/jc.2012-2185 | pmc=3462950 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23043194  }} </ref>


Lipoprotien-X
{{Family tree/start}}
|Pre β-1and α-4 HDL with normal
{{Family tree | | | | | | A01 | | | |A01= HDL <20mg/dl in the absence of severe hypertriglyceridemia}}
{{Family tree | | | | | | |!| | | | | }}
{{Family tree | | | | | | |!| | | | | }}
{{Family tree | | | | | | C01 | | | |C01= Rule out secondary causes of low HDL C<br>Paraproteinemia from multiple myeloma<br>Anabolic steriod use<br>Fibrate use<br>Thiazolidinedione use}}
{{Family tree | | | | | | |!| | | | | }}
{{Family tree | | | | | | |!| | | | | }}
{{Family tree | | | | | | E01 | | | |E01= Consider Monogenic primary disorders<br>Order ApoA1}}
{{Family tree | | | | | | |!| | | | | }}
{{Family tree | | |,|-|-|-|^|-|-|.|}}
{{Family tree | |F01| | | | |F02| |F01= >5mg/dl| F02= Undetectable or <5mg/dl}}
{{Family tree | | |!| | | | | | |!| | | | | | }}
{{Family tree | |G01| | | | |G02| | | |G01=Familial LCAT deficiency <br>High plasma FC:CE ratio<br>2D electrophoresis: Prebeta and Alpha-4, Beta mobility of LDL|G02= Do 2D Gel Electrophoresis with Apo A1 Immunoassay}}
{{Family tree | | | | | | | | | |!| | | | }}
{{Family tree | | | | | | | |,|-|^|-|-|.| }}
{{Family tree | | | | | | | H01| | |H02|H01= Complete absence of Apo A1 containing HDL C|H02= Only Pre-Beta HDL C}}
{{Family tree | | | | | | | |!| | | | |!| }}
{{Family tree | | | | | | |I01| | |I02|I01=Apo A1 Deficiency<br><SMALL>(Confirm with gene sequencing)</SMALL>|I02=Homozygous Tangier Disease<br><SMALL>(Confirm with gene sequencing)</SMALL>}}
{{Family tree/end}}


pre-β LDL.
'''Approach algorithm to a patient with low low LDL C:'''
|Only preβ-1 HDL present
 
|Lack of large α-1 and α-2 HDL particles
{{Family tree/start}}
Normal preβ-1 HDL
{{Family tree | | | | | | A01 | | | |A01= Low LDL C <5th percentile}}
|}
{{Family tree | | | | | | |!| | | | | }}
{{Family tree | | | | | | |!| | | | | }}
{{Family tree | | | | | | C01 | | | |C01= Rule out secondary causes of low LDL}}
{{Family tree | | | | | | |!| | | | | }}
{{Family tree | | | | | | |!| | | | | }}
{{Family tree | | | | | | E01 | | | |E01= Lipid panel}}
{{Family tree | | | | | | |!| | | | | }}
{{Family tree | | |,|-|-|-|^|-|-|.|}}
{{Family tree | |F01| | | | |F02| |F01= Normal Triglycerides| F02=Low Triglycerides}}
{{Family tree | | |!| | | | | | |!| | | | | | }}
{{Family tree | |G01| | | | |G02| | | |G01=Chlyomicron retention disease<br><SMALL>(Confirm with gene sequencing)</SMALL>|G02=Screen the lipid panel of the patient's parents}}
{{Family tree | | | | | | | | | |!| | | | }}
{{Family tree | | | | | | | |,|-|^|-|-|.| }}
{{Family tree | | | | | | | H01| | |H02|H01=Normal Parental Lipid Panel|H02=If Parental Lipid Panel <50% of Normal on:<br>*LDL<br>*Total Cholesterol<br>*Triglycerides}}
{{Family tree | | | | | | | |!| | | | |!| }}
{{Family tree | | | | | | |I01| | |I02|I01=Abetalipoproteinemia<br><SMALL>(Confirm with gene sequencing)</SMALL>|I02=Familial homozygous hypobetalipoproteinemia<br><SMALL>(Confirm with gene sequencing)</SMALL>}}
{{Family tree/end}}
</small>


==References==
==References==

Latest revision as of 14:05, 2 October 2020

Lipid Disorders Main Page

Overview

Causes

Classification

Abetalipoproteinemia
Hypobetalipoproteinemia
Familial hypoalphalipoproteinemia
LCAT Deficiency
Chylomicron retention disease
Tangier disease
Familial combined hypolipidemia

Differential Diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]; Aravind Kuchkuntla, M.B.B.S[3]; Tarek Nafee, M.D. [4] Synonyms and keywords: Hypolipidemia, low lipoprotein

Overview

Hypolipoproteinemia (also known as hypolipidemia or low lipoproteins) is defined as presence of low levels of one or more type of lipoproteins. Hypolipoproteinemia may present as primary genetic disorders or as a secondary complication of underlying medical conditions. After ruling out common secondary causes of hypolipoproteinemia, the clinician must begin the work-up for primary causes. Patients with hypoproteinemia may present with low LDL, or low HDL. Patients with low LDL commonly present with diarrhea, vomiting, or failure to thrive (in infanthood). Patients with primary low HDL are usually asymptomatic however, patients diagnosed with low HDL due to Tangier's disease, ApoA1 deficiency, or LCAT deficiency have specific clinical findings such as corneal opacities, xanthomas, and renal failure. Work up for primary hypolipoproteinemias begins with careful examination of the lipid panel and may involve screening of family members. Confirmatory gene sequencing is the gold standard diagnostic test for all hypolipoproteinemias.

Causes

The following are the list of conditions which can cause low LDL C and low HDL C levels:

Primary lipoprotein abnormalities

  • Hypoalphalipoproteinemia (Apolipoprotein A-1 deficiency). Low HDL
  • Hypobetalipoproteinemia and Abetalipoproteinemia. Low LDL and VLDL, but not low HDL
  • Chylomicron retention disease
  • Cholesteryl ester transfer protein (CETP) elevation
  • Familial combined hypolipidemia (does not increase risk of atherosclerosis)
  • LCAT deficiency
  • Proprotein convertase subtilisin/kexin type 9 (PCSK9) loss of function or deficiency
  • Adenosine triphosphate (ATP)-binding cassette transporter (ABCA1) gene mutations
    • Familial HDL deficiency. This is the most common cause of low HDL and coronary artery disease.
    • Tangier disease

Secondary causes

Classification

Based on the etiology hypolipoproteinemias are classified into primary and secondary hypolipoproteinemias. The following algorithm is a list of various etiologies under primary and secondary hypolipoproteinemias:

 
 
 
 
 
 
Hypolipoproteinemia
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Primary
(Genetic)
 
 
 
 
 
 
 
 
 
 
 
 
 
Secondary
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abetalipoproteinemia
Apolipoprotein 1 deficiency
Chylomicron retention disease
Familial combined hypolipidemia
Hypobetalipoproteinemia
LCAT deficiency
Primary alphalipoproteinemia
PCSK9 deficiency
Tangier disease
 
 
 
 
 
 
 
 
 
 
 
 
 
Anemia
Critical illness
Chronic inflammation
Chronic liver disease
Hyperthyroidism
Infection
Malabsorption
Malignancy

Differential Diagnosis

The table below provides a brief synopsis of the lipid profile findings in several of the most common primary hypolipidemic disorders affecting the LDL C levels:

Abetalipoprotienemia Familial Homozygous

Hypobetalipoproteinemia

Familial Heterozygous

Hypobetalipoproteinemia

PCSK9 deficiency Chylomicron Retention

Disease

Familial Combined

Hypolipidemia

LDL C ↓↓↓ (0) ↓↓↓ ↓↓ ↓↓
Apo B ↓↓↓( 0) ↓↓↓ N ↓↓ N
TG ↓↓↓ ↓↓↓ N
TC ↓↓↓ ↓↓↓ ↓↓
HDL ↓↓ ↓↓ N N ↓↓ ↓↓
VLDL ↓↓ ↓↓ N ↓↓
Apo A1 ↓↓ ↓↓ N ↓↓ N

The table below is a differential diagnosis for low HDL C disorders:

Familial LCAT

Deficiency

Fish Eye

Disease

Homozygous Tangier

Disease

Heterozygous Tangier

Disease

Apo A1 Deficiency
Gene Defect LCAT LCAT ABCA1 ABCA1 Apo A1
Inheritance Autosomal Recessive Autosomal Recessive Autosomal Recessive Autosomal Recessive Autosomal Dominant
Pathogenesis
  • Loss of alpha and beta LCAT function
  • Failure of cholesterol ester formation.
Loss of alpha function only

Pre beta-1 HDL fails to picks up free cholesterol from cells due to mutation in ABCA1 transporter.

Similar to homozygous Defective synthesis of Apo A1 resulting in failure of maturation of HDL and defective reverse cholesterol transport.
Clinical Features
  • Annular corneal opacity
  • Anaemia
  • Progressive renal disease with proteinuria
  • Corneal opacities only
  • Normal renal function
  • Large yellow-orange tonsils
  • Dense central corneal opacity
  • Relapsing and remitting course of neuropathy
Asymptomatic
  • Corneal Opacities
  • Tuboeruptive, Planar and palmar Xanthomas
  • Premature Heart Disease
Lipid Panel
  • Elevated Free cholesterol
  • HDL-C < 10 mg/dL
  • Low Apo A1 and Apo AII
  • Elevated Apo E and Triglycerides
  • Low LDL C
  • Elevated free cholesterol
  • HDL C < 27 mg/dL
  • Apo A1<30mg/dl and low Apo A2
  • Elevated Apo E and Triglycerides
  • Normal LDL and VLDL
  • HDL < 5% of normal
  • Apo A1 < 1% of normal
  • LDL < 40% of normal
  • HDL C, Apo A1 and LDL 50% less than normal.
  • Undetectable Apo A1
  • HDL C less than 10mg/dl
  • Normal or low Apo AII
  • LDL C normal
  • Triglyceride normal or elevated
2D Gel Electrophoresis Pre β-1 and α-4 HDL, LDL with β mobility due to Lipoprotien-X Pre β-1and α-4 HDL with normal pre-β LDL. Only preβ-1 HDL present
  • Lack of large α-1 and α-2 HDL particles
  • Normal preβ-1 HDL
Lack of Apo A1 containing HDL particles.

Approch algorithm to a patient with low HDL C:[1]

 
 
 
 
 
HDL <20mg/dl in the absence of severe hypertriglyceridemia
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Rule out secondary causes of low HDL C
Paraproteinemia from multiple myeloma
Anabolic steriod use
Fibrate use
Thiazolidinedione use
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Consider Monogenic primary disorders
Order ApoA1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
>5mg/dl
 
 
 
 
Undetectable or <5mg/dl
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Familial LCAT deficiency
High plasma FC:CE ratio
2D electrophoresis: Prebeta and Alpha-4, Beta mobility of LDL
 
 
 
 
Do 2D Gel Electrophoresis with Apo A1 Immunoassay
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Complete absence of Apo A1 containing HDL C
 
 
Only Pre-Beta HDL C
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Apo A1 Deficiency
(Confirm with gene sequencing)
 
 
Homozygous Tangier Disease
(Confirm with gene sequencing)

Approach algorithm to a patient with low low LDL C:

 
 
 
 
 
Low LDL C <5th percentile
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Rule out secondary causes of low LDL
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lipid panel
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Normal Triglycerides
 
 
 
 
Low Triglycerides
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chlyomicron retention disease
(Confirm with gene sequencing)
 
 
 
 
Screen the lipid panel of the patient's parents
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Normal Parental Lipid Panel
 
 
If Parental Lipid Panel <50% of Normal on:
*LDL
*Total Cholesterol
*Triglycerides
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abetalipoproteinemia
(Confirm with gene sequencing)
 
 
Familial homozygous hypobetalipoproteinemia
(Confirm with gene sequencing)

References

  1. Rader DJ, deGoma EM (2012). "Approach to the patient with extremely low HDL-cholesterol". J Clin Endocrinol Metab. 97 (10): 3399–407. doi:10.1210/jc.2012-2185. PMC 3462950. PMID 23043194.


Template:WH Template:WS